Dear Friends, It is a great pleasure to know that now Virorav has also come out with the intradermal option (attachment). This will be a further boost to the intradermal ARV campaign in India to controll rabies. After Rabipur, Abhyrab and Indirav, this will be the fourth drug offering a low-cost intradermal option in India. Regards,
Dr. Omesh BhartiM.B.B.S., D.H.M., M.A.E. (Epidemiology)Directorate of Health Safety and Regulation,
Himachal Pradesh+91-9418120302[[email protected]][email protected][/email]; [email protected]
- Page :
- 1
Il n'y a pas encore de réponse à ce message.